Pharmaceutical Industry
Page 11 of 100
By AFPOctober 10, 2024
CommentarySome businesses are now backtracking on DEI. Biopharma cannot afford to and must remain resolute
By Robert BlumOctober 9, 2024
PoliticsMartin Shkreli gets snubbed by the Supreme Court and must return millions he reaped from jacking up the price of a lifesaving drug
By Lindsay Whitehurst and The Associated PressOctober 7, 2024
TechGoogle DeepMind exec says AI will increase efficiency so much it’s expected to handle 50% of info requests in its legal department
By Paolo ConfinoOctober 7, 2024
By Greg McKennaOctober 7, 2024
By Ashleigh Furlong and BloombergOctober 4, 2024
By Beth GreenfieldOctober 2, 2024
By Ryan HoggSeptember 24, 2024
FinanceNovo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
By Sara Sjolin, Sanne Wass, Oliver Crook and BloombergSeptember 23, 2024
By Lindsey LeakeSeptember 21, 2024
LeadershipMark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
By Sydney LakeSeptember 16, 2024
NewslettersEli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
By Sheryl EstradaSeptember 10, 2024
CommentaryAging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it
By Alex ZhavoronkovSeptember 9, 2024
Most Popular
